Alergostop

ALERGOSTOP®

  • Composition
  • Release form
  • Indication
  • Reception scheme
  • Contraindications
Active substance: desloratadine; excipients: lactose, monohydrate, calcium hydrogen phosphate | dihydrate, microcrystalline cellulose, potato starch, pregelatinization starch, sodium starch glycolate (type A), talc, magnesium stearate.
Tablets, film-coated, 5 mg.
Elimination of symptoms associated with:
- allergic rhinitis (sneezing, nasal discharge, itching, edema and nasal congestion and itching and redness of the eyes, tearing, itching and palatum coughing);
- urticaria (itching, rash).
Adults and adolescents (over 12 years): 1 tablet 1 time per day regardless of the meal, to eliminate symptoms associated with allergic rhinitis (including intermittent and persistent allergic rhinitis) and urticaria. Therapy intermittent allergic rhinitis (presence of symptoms less than 4 days per week or less than 4 weeks) should be carried out based on the data history: stop after the disappearance of symptoms and recover after they occur. In persistent allergic rhinitis (presence of symptoms for more than 4 days per week and more than 4 weeks) treatment must continue throughout the period of exposure to the allergen.
Hypersensitivity to loratadine and desloratadine or auxiliary components of the drug.
Price information